Clinical Safety

Tracking Breast Density Changes Over Time Enhances Cancer Risk Prediction
Research & Development Tracking Breast Density Changes Over Time Enhances Cancer Risk Prediction

Breast density is a significant factor in both the risk of developing breast cancer and the effectiveness of mammographic tumor detection. While it is common for breast density to decrease with age, certain patterns of density increase are associated with heightened cancer risk. This article delves

Is Fluticasone-Umeclidinium-Vilanterol Better Than Budesonide for COPD?
Research & Development Is Fluticasone-Umeclidinium-Vilanterol Better Than Budesonide for COPD?

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition that profoundly impacts patients' quality of life and incurs substantial healthcare costs. Effective management of COPD often necessitates the use of inhaled medications, such as corticosteroids, long-acting

Center for Patient Safety Research Leads Efforts to Reduce Healthcare Errors
Research & Development Center for Patient Safety Research Leads Efforts to Reduce Healthcare Errors

Errors in healthcare can have devastating consequences, contributing to an estimated 100,000 premature deaths and over a million injuries annually in the United States, according to the Institute of Medicine's report "To Err is Human." These errors often stem from complex and

How Did a Local Fundraiser Raise Over €4,000 for Breast Cancer Research?
Research & Development How Did a Local Fundraiser Raise Over €4,000 for Breast Cancer Research?

In a remarkable display of community solidarity and corporate responsibility, the small town of Rathkeale witnessed an inspiring event organized at Downes' EUROSPAR, aiming to support the National Breast Cancer Research Institute (NBCRI). Owner Derek Downes, along with his dedicated team,

New Non-Invasive Blood Test Revolutionizes Endometriosis Diagnosis
Research & Development New Non-Invasive Blood Test Revolutionizes Endometriosis Diagnosis

Endometriosis, a chronic and often debilitating condition affecting approximately 190 million women and teenage girls globally, has traditionally been diagnosed through a lengthy and invasive process. For years, women have had to endure intrusive procedures and lengthy waits before receiving a

Can CDKN2A Mutations Be Both Protective and Harmful in Esophageal Cancer?
Research & Development Can CDKN2A Mutations Be Both Protective and Harmful in Esophageal Cancer?

Recent groundbreaking research on genetic mutations in esophageal cancer has revealed surprising insights into the role of the CDKN2A gene. Traditionally seen as a driver of cancer development, this gene might also play a protective role in the early stages of esophageal cancer. This discovery

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later